Global Calcium Pvt. Limited is pleased to announce that the United States Food and Drug Administration (USFDA) has completed its review of the reinspection conducted at the company's manufacturing facility at 125/126 SIPCOT Industrial Complex, Hosur, Tamil Nadu, India.

In a communication dated August 17, 2026, the USFDA confirmed that Global Calcium is no longer subject to refusal of admission under Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act, and that the facility has been formally removed from Import Alert 66-40.

This outcome reflects the company's continued commitment to quality systems and regulatory compliance across its manufacturing operations, and reaffirms Global Calcium's ability to supply the US market without restriction.

Global Calcium remains focused on maintaining the highest standards of quality and compliance across all its facilities.